Russian Ministry of Health in accordance with Article 32 of the Federal Law of 12.04.2010 number 61-FZ "On Circulation of Medicines" decided to cancel state registration and exclusion from the state register of medicines for medical use of the drug(registration certificate LP-001858 dated September 27, 2012 issued by GlaxoSmithKline Trading, Russia):
Tazrobid® (trade name of the drug)
Piperacillin + Tazobactam (international non-proprietary or grouping or chemical name)
lyophilizate for the preparation of a solution for intravenous administration, 2 g + 0.25 g, 4 g + 0.5 g (dosage form, dosage)
Strides Arcolab Limited, India No 152/6 and 154/16 Doresanipalya, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India. (name and address of the location of the manufacturer of the medicinal product)
on the basis of a filing by an authorized legal entity of ZAO GlaxoSmithKline Trading, an application for the cancellation of the state registration of a medicinal product.